Pharmacovigilance study of “Albúmina Sérica Humana 20% UNC tm” (ASH-UNC): interdisciplinary research between industry, hospital and academy

• In: Poster presentation
• At: Buenos Aires (Argentina) (2016)
• Type: Poster
• Poster code: POS-HPS-027
• By: FONTANA, Daniela (Laboratorio de Hemoderivados de la Universidad Nacional de Córdoba, Farmacoepidemiología e Información Científica, Cordoba, Argentina)
• Co-author(s): Patricia Sierra:,Hospital Córdoba,Cordoba,Argentina|Marisel Cian:,Hospital Córdoba,Cordoba,Argentina|Mariana Taran:,Hospital Córdoba,Cordoba,Argentina|Sofia Costamagna:,Facultad de Ciencias Químicas Universidad Nacional de Córdoba,Cordoba,Argentina|Antonella Paez:,Facultad de Ciencias Químicas Universidad Nacional de Córdoba,Cordoba,Argentina|Roxana Rivero:,Laboratorio de Hemoderivados de la Universidad Nacional de Córdoba,Cordoba,Argentina|Carolina Barros:,Laboratorio de Hemoderivados de la Universidad Nacional de Córdoba,Cordoba,Argentina|Catalina Massa:,Laboratorio de Hemoderivados de la Universidad Nacional de Córdoba,Cordoba,Argentina|Daniela Fontana:,Laboratorio de Hemoderivados de la Universidad Nacional de Córdoba,Cordoba,Argentina
  
• Abstract:

  In 2015 ASH-UNC was included in a Risk Management Plan

  Study: observational prospective, 2 stages (2015): 25/03-25/06 and 31/08-31/10

  
  

  Sources: prescription, nursing, pharmacy and medical records, interviews

  
  

  Population: patients requiring ASH-UNC (1st stage) and burned patients with and without ASH (2nd stage)

  
  

  Variables: age, sex, days of

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login